25 Jun dr_kumar_dharmarajan
Posted at 10:46h
in
Dr. Kumar Dharmarajan MD MBA
Yale School of Medicine
Center for Outcomes Research & Evaluation (CORE)Contraindicated Initiation of β-Blocker Therapy in Patients Hospitalized for Heart Failure
